☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
license agreement
Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US
October 19, 2021
AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies
October 12, 2021
Bio-Thera Signs a License Agreement with Intract for Soteria and Phloral Technologies to Develop Oral Antibody Therapies
September 28, 2021
Innovent Signs a License Agreement with Union to Develop & Commercialize Orismilast for Inflammatory Dermatology Conditions in...
September 28, 2021
Sandoz Enters into a Commercialization and License Agreement with Bio-Thera to Commercialize BAT1706- a Proposed Biosimilar Avasti...
September 9, 2021
Bio-Thera and Hikma Sign an Exclusive Commercialization and License Agreement for BAT2206 (biosimilar- ustekinumab) in the US
August 30, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.